Continuing Medical Education: Primary Care CME 2010: Neurology CME 2010: Early Identification, Intervention, and Quality Care in Schizophrenia: Bringing Together Community, Family, and Physicians: Live Webcast: November 3, 2010 - November 3, 2011
http://www.cmenetworks.com/cme/11665/1/Continuing-Medical-Education-Primary-Care-CME-2010--Neurology-CME-2010--Early-Identification-Intervention-and-Quality-Care-in-Schizophrenia-Bringing-Together-Community-Family-and-Physicians-Live-Webcast-November-3-2010---November-3-2011/Page1.html
CME Outfitters
CME Outfitters is an independent accredited healthcare communications agency providing multidisciplinary continuing medical education content development, production, marketing, accreditation, and project management services to the healthcare industry.
By CME Outfitters
Published on 10/28/2010
Early Identification, Intervention, and Quality Care in Schizophrenia: Bringing Together Community, Family, and Physicians
CME Outfitters, LLC
November 3, 2010 - November 3, 2011
In this neuroscienceCME Live and On Demand, the experts will provide clinically relevant practice points for the early identification and clinical management of schizophrenia.
CME Sponsor:
CME Outfitters, LLC
Location: Live Webinar
Course Directors/Instructors:
Jeffrey A. Lieberman, MD (Moderator)
Chairman, Department of Psychiatry
College of Physicians and Surgeons, Columbia University
Director, New York State Psychiatric Institute
Director, Lieber Center for Schizophrenia Research
Psychiatrist-in-Chief at New York Presbyterian Hospital & Columbia University Medical Center
New York, NY
Lisa Dixon, MD, MPH
Professor, University of Maryland School of Medicine
Director, Division of Health Services Research
VA Capitol Health Care Network MIRECC
Baltimore, MD
John W. Newcomer, MD
Gregory B. Couch Professor of Psychiatry, Psychology and Medicine
Director, Clinical Trials Unit, Institute of Clinical and Translational Sciences (ICTS)
Director, Regulatory Support Center, ICTS
Medical Director, Center for Clinical Studies
Washington University School of Medicine
St. Louis, MO
Number of Credits:
1.0 AMA PRA Category 1 Credit™
Registration Fee: Free
More Info
Detailed Description:
Schizophrenia is a disease that begins in early adulthood and places a significant burden on the family and on society. Early identification and treatment that involves collaboration among families, care providers, and the community have been shown to be effective. Treatment that includes pharmacotherapy, psychotherapy, and psychosocial intervention has been shown to reduce the risk of early transition into psychosis in young people who are at risk. Clinicians can make a significant and often lifelong impact if they understand which individuals are at risk and recognize the prodromal symptoms of schizophrenia. Clinicians need to develop a multimodal, collaborative treatment plan for the care of individuals with schizophrenia or early signs of psychosis. Knowledge of standardized, validated assessment tools can assist the clinician in screening for side effects and adherence to treatment. In this neuroscienceCME Live and On Demand, the experts will provide clinically relevant practice points for the early identification and clinical management of schizophrenia.
Learning Objectives:
At the end of this CE activity, participants should be able to:
Physicians, physician assistants, nurses, nurse practitioners, pharmacists, psychologists, social workers, certified case managers, and other health care professionals with an interest in managing patients with schizophrenia
Early Identification, Intervention, and Quality Care in Schizophrenia: Bringing Together Community, Family, and Physicians
CME Outfitters, LLC
November 3, 2010 - November 3, 2011
In this neuroscienceCME Live and On Demand, the experts will provide clinically relevant practice points for the early identification and clinical management of schizophrenia.
Early Identification, Intervention, and Quality Care in Schizophrenia: Bringing Together Community, Family, and Physicians
CME Sponsor:
CME Outfitters, LLC
Location: Live Webinar
Course Directors/Instructors:
Jeffrey A. Lieberman, MD (Moderator)
Chairman, Department of Psychiatry
College of Physicians and Surgeons, Columbia University
Director, New York State Psychiatric Institute
Director, Lieber Center for Schizophrenia Research
Psychiatrist-in-Chief at New York Presbyterian Hospital & Columbia University Medical Center
New York, NY
Lisa Dixon, MD, MPH
Professor, University of Maryland School of Medicine
Director, Division of Health Services Research
VA Capitol Health Care Network MIRECC
Baltimore, MD
John W. Newcomer, MD
Gregory B. Couch Professor of Psychiatry, Psychology and Medicine
Director, Clinical Trials Unit, Institute of Clinical and Translational Sciences (ICTS)
Director, Regulatory Support Center, ICTS
Medical Director, Center for Clinical Studies
Washington University School of Medicine
St. Louis, MO
Number of Credits:
1.0 AMA PRA Category 1 Credit™
Registration Fee: Free
More Info
Detailed Description:
Schizophrenia is a disease that begins in early adulthood and places a significant burden on the family and on society. Early identification and treatment that involves collaboration among families, care providers, and the community have been shown to be effective. Treatment that includes pharmacotherapy, psychotherapy, and psychosocial intervention has been shown to reduce the risk of early transition into psychosis in young people who are at risk. Clinicians can make a significant and often lifelong impact if they understand which individuals are at risk and recognize the prodromal symptoms of schizophrenia. Clinicians need to develop a multimodal, collaborative treatment plan for the care of individuals with schizophrenia or early signs of psychosis. Knowledge of standardized, validated assessment tools can assist the clinician in screening for side effects and adherence to treatment. In this neuroscienceCME Live and On Demand, the experts will provide clinically relevant practice points for the early identification and clinical management of schizophrenia.
Learning Objectives:
At the end of this CE activity, participants should be able to:
- Identify signs and symptoms of prodromal and first-episode psychosis that typically would be seen and could be recognized by both primary care physicians and psychiatrists.
- Customize a medication plan for patients with schizophrenia that uses a structured screening tool to detect lack of adherence and considers tolerability and ease of administration.
- Design a multimodal, individualized treatment and monitoring plan that specifies assessment tool, medication therapy, behavioral therapy, and follow-up regimen for patients with schizophrenia.
Physicians, physician assistants, nurses, nurse practitioners, pharmacists, psychologists, social workers, certified case managers, and other health care professionals with an interest in managing patients with schizophrenia